193 related articles for article (PubMed ID: 2873263)
1. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
[TBL] [Abstract][Full Text] [Related]
2. Participation of the vasodilating property of nipradilol in improving ischemic derangement of myocardial energy metabolism.
Higuchi M
J Cardiovasc Pharmacol; 1989 Jul; 14(1):157-65. PubMed ID: 2475707
[TBL] [Abstract][Full Text] [Related]
3. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs.
Pagel PS; Proctor LT; Devcic A; Hettrick DA; Kersten JR; Tessmer JP; Farber NE; Schmeling WT; Warltier DC
J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):429-34. PubMed ID: 9713732
[TBL] [Abstract][Full Text] [Related]
4. Effects of nipradilol (K-351) on cardiac function in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Takeo S; Ito H; Miyamoto Y; Kato T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):47-55. PubMed ID: 2861795
[TBL] [Abstract][Full Text] [Related]
5. Nipradilol depresses cardiac contractility and O2 consumption without decreasing coronary resistance in dogs.
Zhao DD; Namba T; Araki J; Ishioka K; Takaki M; Suga H
Acta Med Okayama; 1993 Feb; 47(1):29-33. PubMed ID: 8096354
[TBL] [Abstract][Full Text] [Related]
6. Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs.
Vatner SF; Hintze TH
Circulation; 1982 Sep; 66(3):579-88. PubMed ID: 6124327
[TBL] [Abstract][Full Text] [Related]
7. Direct and reflex effects of nitroglycerin on coronary and left ventricular dynamics in conscious dogs.
Vatner SF; Higgins CB; Milland RW; Franklin D
J Clin Invest; 1972 Nov; 51(11):2872-82. PubMed ID: 4404139
[TBL] [Abstract][Full Text] [Related]
8. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
[TBL] [Abstract][Full Text] [Related]
9. Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.
Noguchi K; Sakanashi M
Br J Pharmacol; 1987 Jun; 91(2):411-9. PubMed ID: 2886171
[TBL] [Abstract][Full Text] [Related]
10. Effects of nipradilol, a new beta-adrenoceptor blocking agent with vasodilating properties, on transmural energy metabolism in the underperfused canine heart.
Higuchi M; Asakawa T
Jpn J Pharmacol; 1987 Jun; 44(2):145-53. PubMed ID: 2888916
[TBL] [Abstract][Full Text] [Related]
11. Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs.
Hino T; Hayase N; Chiba K; Ichihara K; Abiko Y
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):373-8. PubMed ID: 2568518
[TBL] [Abstract][Full Text] [Related]
12. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
[TBL] [Abstract][Full Text] [Related]
13. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol.
Um S; Nishida O; Tokubayashi M; Kimura F; Kita T
J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997
[TBL] [Abstract][Full Text] [Related]
14. Systemic and coronary hemodynamic effects of repetitive cocaine administration in conscious dogs.
Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1994 Sep; 24(3):443-53. PubMed ID: 7528301
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
16. Systemic and coronary hemodynamic effects of pinacidil in awake normotensive and hypertensive dogs.
Kawashima S; Liang CS
Hypertension; 1985; 7(4):525-32. PubMed ID: 3891613
[TBL] [Abstract][Full Text] [Related]
17. Decreased regional lactate production and output due to intracoronary continuous infusion of esmolol during acute coronary occlusion in dogs.
Sidi A; Rush W
J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):237-42. PubMed ID: 1677824
[TBL] [Abstract][Full Text] [Related]
18. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog.
Flacke WE; Flacke JW; Bloor BC; McIntee DF; Sagan M
J Cardiothorac Vasc Anesth; 1993 Feb; 7(1):41-9. PubMed ID: 8094301
[TBL] [Abstract][Full Text] [Related]
19. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
